XIX International AIDS Conference. Interview with Gregg Alton from the Gilead Sciences, Inc. a pharmaceutical company working with health care services, policy makers, etc. to develop effective treatment, treatment as prevention and promoting access to care.

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

XIX International AIDS Conference. Interview with the Immunologist Michael Elliot from University of Rochester on the CNIHR program which involves scientist not previously engaged in the HIV research field to develop new thinking withing the field.

Mary-Jane Matsolo visits a traditional healer and talks about their important role in the fight against HIV and AIDS. She says that traditional healers are often more trusted than conventional health personnel, and that they are often well educated in HIV and AIDS.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Dr Daria Hazuda from MSD, who has been involved in antiretroviral drug development during the past 20 years, holds a presentation. She is also interviewed about leadership and the progress of ARV and vaccine development.

M.D. Mervyn Silverman is one of the pioneers in the HIV/AIDS epidemic. Here he talks about the shifts of topics on the International AIDS Conferences between 1985 and 2008, about the so called San Francisco Model of AIDS care, and about the closing of the Bathhouses.

Joep Lange discusses his views on antiretroviral drugs, both in the developing and the developed world, future improvements of HIV drugs and treatment, and a possible vaccine.

Joep Lange discusses his views on antiretroviral drugs, both in the developing and the developed world, future improvements of HIV drugs and treatment, and a possible vaccine.